Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Checkpoint inhibitors in the treatment of thoracic malignancies

Sanjay Popat • 15 May 2020
Lung Cancer

Sanjay Popat, BSc, MBBS, FRCP, PhD, of The Royal Marsden NHS Foundation Trust, London, UK, discusses a review paper published in The Journal of Thoracic Oncology around the use and role of checkpoint inhibitors in thoracic malignancies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Sanjay Popat

0:34
VJOncology at BTOG 2023
Sanjay Popat • 28 Apr 2023
0:34
VJOncology at BTOG 2023
Sanjay Popat • 28 Apr 2023
1:21
SYSTEMS-2: Radiotherapy and potential survival benefits in mesothelioma
Sanjay Popat • 29 Apr 2023
2:18
Highlights from BTOG 2023
Sanjay Popat • 28 Apr 2023

Related Videos

1:03
The benefits of liquid biopsies for lung cancer in the community setting
Deepti Behl • 9 Apr 2024
0:57
STK-012-101: STK-012 in advanced solid tumors
Alexander Spira • 15 Mar 2024
3:34
FLAURA2: EGFRm dynamics in NSCLC treated with osimertinib
Pasi Jänne • 8 Apr 2024
0:54
FURVENT: furmonertinib in EGFR exon 20 mutant NSCLC
Alexander Spira • 15 Mar 2024
The content of VJOncology is intended for healthcare professionals